Connectivity of rapid-testing diagnostics and surveillance of infectious diseases

Bulletin of the World Health Organization
Volume 97, Number 3, March 2019, 169-244
https://www.who.int/bulletin/volumes/97/3/en/

Connectivity of rapid-testing diagnostics and surveillance of infectious diseases
– Damien Ming, Timothy Rawson, Sorawat Sangkaew, Jesus Rodriguez-Manzano, Pantelis Georgiou & Alison Holmes
http://dx.doi.org/10.2471/BLT.18.219691
The World Health Organization (WHO) developed the ASSURED criteria to describe the ideal characteristics for point-of-care testing in low-resource settings: affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free and deliverable.1 These standards describe. Over the last decade, widespread adoption of point-of-care testing has led to significant changes in clinical decision-making processes. The development of compact molecular diagnostics, such as the GeneXpert® platform, have enabled short turnaround times and allowed profiling of antimicrobial resistance. Although modern assays have increased operational requirements, many devices are robust and can be operated within communities with minimal training. These new generation of rapid tests have bypassed barriers to care and enabled treatment to take place independently from central facilities. Here we describe the importance of connectivity, the automatic capture and sharing of patient healthcare data from testing, in the adoption and roll-out of rapid testing…